2026-526888-37-00招募中2 期
A Long-Term Follow-Up Study to Assess the Safety and Efficacy of B-Cell-Directed Therapy in Patients with Systemic Autoimmune Disease (B-CARE)
Universitaetsklinikum Erlangen AöR1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Klinik für Rheumatologie und Immunologie
Scientific
Universitaetsklinikum Erlangen AöR
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy ParticipantsEpilepsy, amotrophic lateral sclerosis, neuropathy2025-524310-28-00Quralis Corp.48
招募中
1 期
A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D MutationKRAS G12D Mutated Advanced Solid Tumors2025-521062-10-00Arvinas Operations Inc.51
已完成
1 期
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)Healthy Volunteers2023-505684-36-00Janssen - Cilag International92
进行中（未招募）
4 期
A Prospective Study of the Efficacy and Safety of Polycaprolactone (PCL) Collagen Stimulator in Facial Rejuvenation and ContouringPatients with mid to moderate facial laxityfacial laxityfacial contourPolycaprolactone (PCL) fillerneocollagenesisTCTR20260718006Rungsima Wanitphakdeedecha30
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).liver cirrhosis2024-515074-26-00AgomAb Therapeutics64